FAMILIAL HYPERCHOLESTEROLEMIA - HOMOZYGOUS

Clinical trials for FAMILIAL HYPERCHOLESTEROLEMIA - HOMOZYGOUS explained in plain language.

Never miss a new study

Get alerted when new FAMILIAL HYPERCHOLESTEROLEMIA - HOMOZYGOUS trials appear

Sign up with your email to follow new studies for FAMILIAL HYPERCHOLESTEROLEMIA - HOMOZYGOUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Hope for youngest hearts: new drug trial targets rare, dangerous childhood cholesterol

Disease control Recruiting now

This study is testing a drug called inclisiran to see if it is safe and effective at lowering very high 'bad' cholesterol (LDL-C) in children aged 2 to under 12 who have a rare, severe genetic condition. For the first year, children will randomly receive either the drug or a plac…

Matched conditions: FAMILIAL HYPERCHOLESTEROLEMIA - HOMOZYGOUS

Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

FAMILIAL HYPERCHOLESTEROLEMIA - HOMOZYGOUS

Get alerted when new FAMILIAL HYPERCHOLESTEROLEMIA - HOMOZYGOUS trials appear

Hope for youngest hearts: new drug trial targets rare, dangerous childhood cholesterol